Skip to main content
Guidance

MHRA AdvanceGxP service: building compliance into innovation earlier

A new MHRA service being developed to help organisations working on novel medicines technologies consider Good Practice requirements earlier.

AdvanceGxP is a new MHRA service being developed to help organisations working on novel medicines technologies consider Good Practice requirements earlier, reducing regulatory uncertainty while maintaining independent regulatory and inspection decision-making.

Developed with the Office for Life Sciences, AdvanceGxP will initially focus on disruptive innovation in medicines manufacturing. As the service develops, it will explore how earlier, practical and principles-based regulatory support can help innovators make better-informed decisions before critical development, manufacturing and investment choices are fixed.

The need for AdvanceGxP

Innovation in medicines and advanced manufacturing is moving quickly. For organisations developing emerging technologies, there may be limited precedent, detailed guidance or case studies showing how established Good Practice principles will apply. This can create uncertainty at precisely the point when important decisions about facilities, processes, validation and investment are being made.

AdvanceGxP is being developed to help close that gap

By bringing regulatory and compliance thinking into development earlier, AdvanceGxP aims to help organisations understand relevant Good Practice principles, identify potential issues and build compliance into innovation from the outset. This can help organisations make better-informed decisions and manage regulatory and compliance risks within their own development programmes.

Earlier access to practical Good Practice expertise

When fully operational, AdvanceGxP will provide earlier access to practical, regulator-led Good Practice expertise for organisations developing novel and potentially disruptive medicines technologies. The service is being designed to:

  • help organisations explore how Good Practice principles may apply to emerging technologies
  • support earlier consideration of compliance, before key development decisions are fixed
  • provide practical regulatory and compliance insight
  • connect seamlessly with wider MHRA services and regulatory pathways.

AdvanceGxP will complement existing MHRA services and formal inspection. It will not be an inspection or pre-inspection clearance, prescribe a particular technical solution, or guarantee a future regulatory or inspection outcome.

Developing the service

AdvanceGxP is not yet open for applications. We are currently developing the service, including eligibility criteria and how organisations will access support.

Testing and piloting early phases

The initial focus will be deliberately limited while we test demand, capacity, user experience and the types of support that provide most value.

Fees and charges

There will be no charge for accessing AdvanceGxP as we progress through the testing and pilot phases. The developing service is supported by government funding while we develop and test the service, including demand, the types of support required and the longer-term operating model.

Any future charging arrangements for AdvanceGxP will be informed by evidence from the development phases and will be communicated before fees or charges are introduced. Fees for other MHRA chargeable services will continue to apply where an organisation chooses or needs to use those services.

Register your interest in AdvanceGxP

If your organisation is developing a novel or potentially disruptive medicines technology, an application for AI, or a sustainability element to chemistry, manufacture and controls (CMC), and you would like to help us test and the develop the AdvanceGxP service, we’d like to hear from you.

Tell us a little about your organisation and area of innovation and we will review your expression of interest to understand emerging demand for AdvanceGxP. We may also invite you to take part in focus or test groups to help us refine aspects of this new service.

Please note: AdvanceGxP is still being developed. Submitting this form is not an application for regulatory advice or support and does not guarantee participation in the pilot.

Keep up to date

We will be publishing further updates and more information over the coming weeks as we reveal more about the service. To stay informed, register for updates.

Sign up for emails or print this page